(MedPage Today) — SAN FRANCISCO — Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy (MDT) in addition to systemic treatment, a meta-analysis of recent studies showed…
Source link : https://www.medpagetoday.com/meetingcoverage/mgucs/114244
Author :
Publish date : 2025-02-14 22:19:08
Copyright for syndicated content belongs to the linked Source.
